Bruker Corporation declared a quarterly cash dividend of $0.05 per share on its common stock. The dividend was announced on August 14, 2026, with a record date of September 21, 2026, and is scheduled to be paid on October 7, 2026. Bruker Corporation operates in the scientific instruments industry, designing and manufacturing analytical instruments for research and industrial applications.

Bruker Corporation reported second quarter 2026 financial results on August 4, 2026. Total revenue reached $838.5 million, a 5.2% increase year-over-year, driven by organic growth of 2.8%. The Scientific Instruments segment saw bookings rise 10% organically with a book-to-bill ratio exceeding 1.0x. GAAP diluted loss per share was $(0.41), reflecting a $134.9 million goodwill impairment charge, while non-GAAP diluted EPS improved to $0.49 from $0.32 in the prior year period. The company updated its full-year 2026 guidance, projecting revenues of $3.54 to $3.57 billion and non-GAAP EPS of $2.10 to $2.15. Bruker Corporation operates in the scientific instruments industry, providing analytical solutions for life science research, diagnostics, and semiconductor metrology.

Bruker Corporation declared a quarterly cash dividend of $3.9844 per share on its 6.375% Mandatory Convertible Preferred Stock, Series A. The declaration occurred on July 30, 2026, with a record date of August 15, 2026, and payment scheduled for September 1, 2026. Bruker Corporation operates in the scientific instruments industry, designing and manufacturing analytical instruments and life science tools.